View in EDS

Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.

Saved in:
Bibliographic Details
Title: Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
Authors: Rustandi RR; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: richard_rustandi@merck.com., Hamm M; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Onimus M; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Yuan Y; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Anderson CL; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA., Zong C; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.
Source: Vaccine [Vaccine] 2022 Oct 06; Vol. 40 (42), pp. 6012-6016. Date of Electronic Publication: 2022 Sep 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36123258
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rustandi+RR%22">Rustandi RR</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: richard_rustandi@merck.com.<br /><searchLink fieldCode="AU" term="%22Hamm+M%22">Hamm M</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Onimus+M%22">Onimus M</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+CL%22">Anderson CL</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zong+C%22">Zong C</searchLink>; Analytical Research & Development, Merck & Co., Inc., Kenilworth, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2022 Oct 06; Vol. 40 (42), pp. 6012-6016. <i>Date of Electronic Publication: </i>2022 Sep 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36123258
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2022.09.026
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6012
    Titles:
      – TitleFull: Monitoring bromide loss in bromoacetyl-derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by capillary electrophoresis and NMR spectroscopy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rustandi RR
      – PersonEntity:
          Name:
            NameFull: Hamm M
      – PersonEntity:
          Name:
            NameFull: Onimus M
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Anderson CL
      – PersonEntity:
          Name:
            NameFull: Zong C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 10
              Text: 2022 Oct 06
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 42
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1